December 7, 2022

The Global Protein Supplements Market is projected to witness a CAGR of 7. 8% during the forecast period (2022 – 2027). Protein supplements are popular among gym fanatics, and fitness enthusiasts, as they influence various aspects of the body such as muscle growth, metabolism, energy levels, heart health, and weight management.
New York, Sept. 27, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Protein Supplements Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” – https://www.reportlinker.com/p06321509/?utm_source=GNW
The diversity of protein supplements, in terms of claims, protein content, sources, forms, and flavors, is catering to a wide consumer group around the globe and driving the market actively. It is expected to continue gaining momentum during the forecast period as well. Additionally, the increasing demand for plant-based protein is expected to push manufacturers to bring organic and clean-label protein supplements across the market channels.

With the onset of Covid-19, protein supplements gained increased prominence for their apparent ability to enhance immunity. As per a two-week survey conducted by Glanbia PLC, a key nutrition products producer, in April 2020 to track the impact of COVID-19 on consumers spending on food and nutrition products in the United States, the percentage of respondents who consumed protein bars to stay healthy and boost immunity increased from 21% in week 1 to 23% in week 2 of March 2020. The consumption of ready-to-drink protein shakes also increased substantially post-pandemic.

?Furthermore, the rising prominence of sports activities, celebrity endorsements, international sports and fitness events, social media influencers, and various government initiatives and campaigns, encourage consumers to participate in various fitness and sports-related activities, thus contributing to the increasing expenditure on maintaining a healthy lifestyle.

However, government scrutiny in the sports nutrition category, including protein supplements, continues to affect the types of products introduced to the market. The lack of proper guidelines and regulatory framework has resulted in many protein supplements recalls.

Key Market Trends
Market Diversity & Product Innovation is the Propelling Protein Supplement Demand

Protein has become a popular macronutrient among all consumers, including athletes looking for a competitive edge, aging seniors intent on maintaining muscle mass, and busy individuals who are opting for meal-replacement protein bars and shakes, among other protein supplement types. Specialty diet trends, like paleo, ketogenic, and Whole30, which emphasize fat and protein over carbohydrates and sugar, have compelled a growing number of people to assess their protein intake and seek out new sources, which in turn is further supporting the protein supplement demand across the globe. Meanwhile, commitments to active living and healthy aging drive the protein supplement market in fresh directions. As consumers from various backgrounds with different health goals, lifestyles, and values continue to add more protein to their diet, companies have formulated innovative protein supplements and other functional nutrition products with high protein and in multiple flavors to satisfy burgeoning demand. For instance, in March 2022, MusclePharm, a global provider of leading sports nutrition and lifestyle branded nutritional supplements, launched a high whey protein drink line (Ready-To-Drink protein drink) with over 20g of protein, in multiple, sugar-free flavors.

Asia-Pacific Holds a Significant Share In The Market

The Asia-Pacific region holds a significant share in the market studied and has witnessed rapid growth in recent years owing to a higher percentage of young consumers and rising disposable income levels. China is expected to lead the growth of the region, owing to government initiatives promoting increased participation in sports and fitness activities as a means for residents to lead active and healthier lifestyles. The increasing emergence and rising penetration of various sports leagues, including the Chinese Super League, and ASEAN Basketball League, are creating a culture of fitness and active lifestyles, thereby, driving the protein supplements market in China. In many Asian countries, there has been a discernible change in the lifestyles of consumers, as a larger population participates more frequently in sports, marathons, gyms, fitness clubs, and trekking activities to maintain their physical fitness. This trend has led a growing number of consumers to adopt numerous protein-supplement products, either for pre- or post-workouts. For instance, according to a study published by Food Science and Nutrition Technology, in Malaysia, around 73.7% of the consumers preferred protein shakes, and 68.3% of the consumers preferred whey protein among supplement users exercising in the gym in 2021.

Competitive Landscape
The global protein supplements market is fragmented with the presence of a number of regional and global players. The players with substantial market shares include Glanbia PLC, Mondelez International Inc., Meiji Holdings Company, Post Holdings, Inc., and The Hut Group. Companies are increasing their investments in research and development (R&D) and marketing and are expanding their distribution channels to maintain their position in the market. Furthermore, they are adopting competitive strategies by investing more to develop products according to the tastes and preferences of the new-generation customers. Along with a strong product portfolio, the companies use various corporate strategies like partnerships, mergers, and acquisitions to penetrate the protein supplements market. For instance, in November 2021, Six Star Pro Nutrition announced a partnership with the United States national soccer team player and European star Weston McKennie to promote active nutrition on and off the pitch.

Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
Read the full report: https://www.reportlinker.com/p06321509/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

Carly is staying on top of the story and reports that there is “no immediate fix.” Eyeing that sweet capital: Manish has a scoop that Uniswap Labs, a decentralized exchange, is going after over $100 million in new funding. Stream on: YouTube TV is offering a new à la carte option that enables subscribers to purchase stand-alone networks without subscribing to the full channel lineup in its Base plan, Lauren reports.
Two marathon runners tell BBC Newsbeat about overcoming the odds to compete in the London Marathon.
Tesla deliveries in the third quarter will hit a record, but the EV giant has demand concerns in China. Tesla stock is below key levels.
The Food and Drug Administration granted Amylyx Pharmaceuticals a hard-won approval in ALS treatment, but AMLX stock sank Friday.
Motley Fool contributor Jason Hall talks about why he owns QuantumScape (NYSE: QS) stock. This battery technology innovator could hold the key to solid-state batteries. Find out what these groundbreaking batteries could mean for electric vehicles and more in the video.
In the past two years, biotech companies Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) rose to fame thanks to their successful attempts to develop vaccines for COVID-19 and help us end the outbreak. The pandemic isn't over yet, but Moderna and Novavax have given up substantial chunks of their value in the past year. Where does that leave Moderna and Novavax?
UnitedHealth Group stock has been outperforming for months as it ignores the weakness in the broader market averages. Previous tests of the 200-day moving average line were buying opportunities in October and May and June. UNH is again testing the rising 200-day line but the result could be different — the trading volume has increased in September as prices pulled back and this could be a sign that traders are voting with their feet.
Leading drug company Eli Lilly broke above its buy point of 335.43 from a flat base on Wednesday. Trading surged to almost twice the usual volume as investors bought shares of the leading biopharmaceutical company. Shares also surged in sympathy after Biogen's successful trial for a drug to treat Alzheimer's, announced on Thursday.
From upstream activities to midstream, prospects for companies are rosy now, enhancing the outlook for the Zacks Oil & Gas US Integrated industry. COP, OXY, HES and WHD will make the most of the favorable business scenario.
Charles River Laboratories is a pharmaceutical company that specializes in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services. The cutting-edge Massachusetts-based company has been upgraded to a fundamental "buy" recommendation by a sell-side firm with a $240 price target. In the daily bar chart of CRL, below, we can see that the shares have been in a steady downtrend the past 12 months.
Life for the car manufacturers is becoming tougher as the economic slowdown worsens. Demand for cars is likely to sharply slow as consumers delay buying a new vehicles. "This is in keeping with our macroeconomic board's reduced forecast for 2.5% global GDP growth this year and 2.1% in 2023 … on the back of substantial inflation, and higher interest rates meant to tame it," Moody's explained.
(Bloomberg) — Senior Biden administration officials pressed executives from some of the largest US gasoline producers to curtail overseas sales during a tense meeting Friday afternoon, suggesting that without voluntary action, the government could force the industry to stockpile more fuel in US tanks.Most Read from BloombergMacKenzie Scott Files for Divorce From Science Teacher HusbandTop Apple Executive Is Leaving After Making Crude Remarks in TikTok VideoMeta to Cut Headcount for First Time,
In the weeks after Russia's invasion of Ukraine on Feb. 24, Claudio Descalzi, CEO of Italian energy major Eni, embarked on a whirlwind of trips to gas suppliers in Africa. The visits included meetings with officials in Algeria in February plus talks in Angola, Egypt and Republic of Congo in March, with Descalzi often accompanied by senior Rome officials, according to company and government releases. State-controlled Eni and Italy were able to leverage existing supply relationships with those nations to secure extra gas to replace a large part of the volumes it received from its top supplier Russia.
Oil markets were relatively unscathed by Hurricane Ian, but another bullish catalyst is already looming over oil prices
Just when we thought Americans were going to get some relief from high prices at the pump, Californians got hit hard with a jump. As of Sept. 30, California is paying an average of $6.29 — much…
A neurosurgeon on TikTok has revealed five things you should never do to have a healthy brain.Source: SWNS
Yahoo Finance's Brad Smith breaks down leading business headlines, including leadership changes at Apple and Disney as well as Google winding down its cloud gaming service Stadia.
Investors were delighted to learn that an important source of revenue could be on its way to returning.
If approved, BioMarin's (BMRN) valoctocogene roxaparvovec will be the first gene therapy for hemophilia A in the United States. The FDA filing also incorporates BMRN's responses to the CRL issued to the BLA in 2020.

source

Leave a Reply